Literature DB >> 18923655

Normal peak nasal inspiratory flow rate values in Greek children and adolescents.

A Papachristou1, E Bourli, D Aivazi, E Futzila, Th Papastavrou, Th Konstandinidis, E Maratou, G Ilonidis, V Aivazis.   

Abstract

BACKGROUND AND AIM: Peak Nasal Inspiratory Flow Rate (PNIFR) is a clinical trial that has been instituted in clinical practice in order to determine the extent of nasal airway patency and it is used to assess the degree of nasal obstruction. This study attempts to provide tables referring to normal values of PNIFR in children and adolescents. PATIENTS AND METHODS: Three thousand one hundred and seventy pupils aged between 5-18 years, were selected to enter the study. Children with acute or chronic upper airway obstruction, such as acute obstructive pulmonary disease or allergic rhinitis and children below the 3rd percentile for weight and/or height were excluded from the study. All children that took part in the study were subjected to PNIFR measurements by using a portable Youlten Peak Flow meter.
RESULTS: A continuous increase of PNIFR values for boys and girls in relation to age increase was recorded. PNIFR values were higher in boys compared to girls and this difference was statistically significant until the age of 12.
CONCLUSION: Normal ranges for PNIFR standards are of great importance for the study of nasal patency, evaluation of the degree of nasal obstruction and application of treatment. This is the first time that a detailed description of PNIFR standards becomes available for the Greek population of children and adolescents.

Entities:  

Keywords:  adolescents; children; nasal inspiratory flow rate; normal values

Year:  2008        PMID: 18923655      PMCID: PMC2464304     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  32 in total

1.  The objective assessment of nasal patency.

Authors:  A S Jones; L Viani; D Phillips; P Charters
Journal:  Clin Otolaryngol Allied Sci       Date:  1991-04

2.  Maximum airflow through the nose in humans.

Authors:  J Pertuze; A Watson; N B Pride
Journal:  J Appl Physiol (1985)       Date:  1991-03

Review 3.  Compilation of reference values for lung function measurements in children.

Authors:  P H Quanjer; J Stocks; G Polgar; M Wise; J Karlberg; G Borsboom
Journal:  Eur Respir J Suppl       Date:  1989-03

4.  Peak inspiratory flow rate is more sensitive than acoustic rhinometry or rhinomanometry in detecting corticosteroid response with nasal histamine challenge.

Authors:  Andrew M Wilson; Erika J Sims; Fiona Robb; Wendy Cockburn; Brian J Lipworth
Journal:  Rhinology       Date:  2003-03       Impact factor: 3.681

5.  Assessment of nasal airway patency: a comparison of four methods.

Authors:  M J Gleeson; L J Youlten; D M Shelton; M Z Siodlak; N M Eiser; C L Wengraf
Journal:  Clin Otolaryngol Allied Sci       Date:  1986-04

Review 6.  Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society.

Authors:  P H Quanjer; G J Tammeling; J E Cotes; O F Pedersen; R Peslin; J C Yernault
Journal:  Eur Respir J Suppl       Date:  1993-03

7.  Evaluation of treatment response in patients with seasonal allergic rhinitis using domiciliary nasal peak inspiratory flow.

Authors:  A Wilson; O J Dempsey; E J Sims; W J Coutie; M C Paterson; B J Lipworth
Journal:  Clin Exp Allergy       Date:  2000-06       Impact factor: 5.018

8.  Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version.

Authors:  Cynthia L Ogden; Robert J Kuczmarski; Katherine M Flegal; Zuguo Mei; Shumei Guo; Rong Wei; Laurence M Grummer-Strawn; Lester R Curtin; Alex F Roche; Clifford L Johnson
Journal:  Pediatrics       Date:  2002-01       Impact factor: 7.124

9.  Efficacy and tolerability of budesonide aqueous nasal spray in chronic rhinosinusitis patients.

Authors:  Valerie J Lund; John H Black; László Z Szabó; Camilla Schrewelius; Anders Akerlund
Journal:  Rhinology       Date:  2004-06       Impact factor: 3.681

10.  Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee.

Authors: 
Journal:  Lancet       Date:  1998-04-25       Impact factor: 79.321

View more
  5 in total

1.  The physiological impact of high altitude on nasal and lower airway parameters.

Authors:  Cemal Cingi; Adin Selcuk; Fatih Oghan; Yezdan Firat; Ali Guvey
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-12-23       Impact factor: 2.503

2.  Peak nasal inspiratory flow: a useful and handy tool for the diagnosis of nasal obstruction in the elderly.

Authors:  Giancarlo Ottaviano; Valerie J Lund; Ennio Nardello; Bruno Scarpa; Ioannis Mylonakis; Giuliana Frasson; Valentina Iacono; Enzo Manzato; Gino Marioni; Alberto Staffieri
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-01-01       Impact factor: 2.503

3.  Accuracy of peak nasal flow to determine nasal obstruction in patients with allergic rhinitis.

Authors:  Gardênia Maria Martins de Oliveira; Marco Aurélio de Valois Correia Júnior; Emilia Chagas Costa; Georgia Véras de Araújo Gueiros Lira; José Ângelo Rizzo; Steve Hunter; Nádia Gaua; Emanuel Sávio Cavalcanti Sarinho
Journal:  Acta Otorhinolaryngol Ital       Date:  2022-04       Impact factor: 2.618

4.  Perceptual accuracy of upper airway compromise in children: Clinical relevance and future directions for research.

Authors:  Daphne Koinis-Mitchell; Cynthia Esteban; Sheryl J Kopel; Barbara Jandasek; Katie Dansereau; Gregory K Fritz; Robert B Klein
Journal:  Allergy Rhinol (Providence)       Date:  2013

5.  Variations in peak nasal inspiratory flow among healthy students after using saline solutions.

Authors:  Jaime Olbrich Neto; Sandra Regina Leite Rosa Olbrich; Natália Leite Rosa Mori; Ana Elisa de Oliveira; José Eduardo Corrente
Journal:  Braz J Otorhinolaryngol       Date:  2015-09-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.